Clinical Trial Update: Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 trial of AV650 for spasticity due to spinal cord injury was terminated; the update reports safety and preliminary effectiveness data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity

Drugs mentioned

• AV650

Snippet

Sponsor: Avigen | Conditions: Muscle Spasticity | Phase 2 | Status: TERMINATED